Steven C. Quay - President & CEO, Director at ATOSSA THERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
ATOS on Nasdaq
All Insider Reports
All Insider Reports

Steven C. Quay - trading volume in the past year for ATOSSA THERAPEUTICS, INC.

Holdings reported by Steven C. Quay for ATOSSA THERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (right to buy) 950,000 $572,850 $0.6030 20 Jan 2026 Direct Common Stock
Common Stock 345,572 $203,887 $0.5900 20 Jan 2026 Direct
Common Stock 22,254 $13,129 $0.5900 20 Jan 2026 By Ensisheim Partners, LLC
Stock Option (right to buy) 1,366,062 15 May 2025 Direct Common Stock

Transactions reported by Steven C. Quay for ATOSSA THERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.